The application of CAR-T cell therapy in hematological malignancies: advantages and challenges - ScienceDirect
Chimeric antigen receptor (CAR)-T cells from multiple myeloma (MM)... | Download Scientific Diagram
CAR T-cell therapy in multiple myeloma: more room for improvement | Blood Cancer Journal
CAR T-Cell Therapy Approved for Multiple Myeloma - NCI
CAR-T with synthetic binder shows 'very promising' results in advanced multiple myeloma
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma | Journal of Hematology & Oncology | Full Text
CAR T-cell therapy for patients with multiple myeloma | BLCTT
FDA Approves Carvykti CAR T-Cell Therapy for Multiple Myeloma - NCI
Overview of Key Early-phase CAR T-cell Therapy Studies in Relapsed or Refractory Multiple Myeloma - MYELOMA360
CAR T-cell therapy for multiple myeloma: state of the art and prospects - The Lancet Haematology
CAR T-Cell: What you Need to Know | Int'l Myeloma Fn
CAR T-Cell Clinical Trial Has Multiple Myeloma Patient Back On Her Feet | Dana-Farber Cancer Institute
CAR T cell therapies for patients with multiple myeloma | Nature Reviews Clinical Oncology
Frontiers | CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
CAR-T Cell Therapy - Advances in The Management of Multiple Myeloma - CancerConnect
CAR T-cell therapy for multiple myeloma: state of the art and prospects - The Lancet Haematology
New immunotherapy sends multiple myeloma into remission
CAR T-Cell Therapy for Multiple Myeloma - NCI
GPRC5D-Targeted CAR T Cells for Myeloma | NEJM
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells - ScienceDirect
New clinical trial tests CAR T-cell therapy for multiple myeloma | Center for Cancer Research
Chimeric antigen receptor T cell therapy for multiple myeloma | Inflammation and Regeneration | Full Text
